Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
In preclinical research, AOD9604 is primarily investigated for its selective lipolytic activitythe ability to stimulate fat breakdown (lipolysis) and inhibit fat synthesis (lipogenesis) without exhibiting the growth-promoting or diabetogenic effects of full-length growth hormone
Reach out now and schedule a consultation towards a healthier, more vibrant life today!
Published research characterises AOD-9604 as retaining the lipolytic domain of hGH while lacking measurable activity at the GH receptor animal-model studies have therefore reported lipolytic effects without the IGF-1, insulin-resistance or growth-promoting changes associated with intact growth hormone
In the first four weeks, many users experience noticeable body weight loss (typically 5-10 pounds), along with improved appetite control
